{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:09:22Z","timestamp":1792800562118,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["268555672 \u2013 SFB A1213"],"award-info":[{"award-number":["268555672 \u2013 SFB A1213"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["268555672 \u2013 SFB A1213"],"award-info":[{"award-number":["268555672 \u2013 SFB A1213"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Morbus Osler Foundation Germany"},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EO1503"],"award-info":[{"award-number":["01EO1503"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BRAHMS \u2013 Thermo Fisher Scientific","id":[{"id":"https:\/\/ror.org\/03x1ewr52","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      A genetic predisposition can lead to the rare disease pulmonary arterial hypertension (PAH). Most mutations have been identified in the gene\n                      <jats:italic>BMPR2<\/jats:italic>\n                      in heritable PAH. However, as of today 15 further PAH genes have been described. The exact prevalence across these genes particularly in other PAH forms remains uncertain. We present the distribution of mutations across PAH genes identified at the largest German referral centre for genetic diagnostics in PAH over a course of\u2009&gt;\u20093\u00a0years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Our PAH-specific gene diagnostics panel was used to sequence 325 consecutive PAH patients from March 2017 to October 2020. For the first year the panel contained thirteen PAH genes:\n                      <jats:italic>ACVRL1, BMPR1B, BMPR2, CAV1, EIF2AK4, ENG, GDF2, KCNA5, KCNK3, KLF2, SMAD4, SMAD9<\/jats:italic>\n                      and\n                      <jats:italic>TBX4.<\/jats:italic>\n                      <jats:sc>T<\/jats:sc>\n                      hese were extended by the three genes\n                      <jats:italic>ATP13A3, AQP1<\/jats:italic>\n                      and\n                      <jats:italic>SOX17<\/jats:italic>\n                      from March 2018 onwards following the genes\u2019 discovery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 79 mutations were identified in 74 patients (23%). Of the variants 51 (65%) were located in the gene\n                      <jats:italic>BMPR2<\/jats:italic>\n                      while the other 28 variants were found in ten further PAH genes. We identified disease-causing variants in\u00a0the genes\n                      <jats:italic>AQP1, KCNK3<\/jats:italic>\n                      and\n                      <jats:italic>SOX17<\/jats:italic>\n                      in families with at least two PAH patients\n                      <jats:italic>.<\/jats:italic>\n                      Mutations were not only detected in patients with heritable and idiopathic but also with associated PAH.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Genetic defects were identified in 23% of the patients in a total of 11 PAH genes. This illustrates the benefit of the specific gene panel containing all known PAH genes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-022-01987-x","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T08:09:05Z","timestamp":1648454945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7288-8297","authenticated-orcid":false,"given":"Christina A.","family":"Eichstaedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Sa\u00dfmannshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Memoona","family":"Shaukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Xanthouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein-Ardeschir","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Seyfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Lerche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Halank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Kleymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satenik","family":"Harutyunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Egenlauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Milger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Ewert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius M.","family":"Hoeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Lankeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias J.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hinderhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Gr\u00fcnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,27]]},"reference":[{"key":"1987_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67\u2013119.","journal-title":"Eur Heart J"},{"key":"1987_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/01.CIR.102.10.1145","volume":"102","author":"E Gr\u00fcnig","year":"2000","unstructured":"Gr\u00fcnig E, Janssen B, Mereles D, Barth U, Borst MM, Vogt IR, Fischer C, Olschewski H, Kuecherer HF, K\u00fcbler W. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation. 2000;102:1145\u201350.","journal-title":"Circulation"},{"key":"1987_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/303059","volume":"67","author":"Z Deng","year":"2000","unstructured":"Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000;67:737\u201344.","journal-title":"Am J Hum Genet"},{"key":"1987_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/79226","volume":"26","author":"KB Lane","year":"2000","unstructured":"Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet. 2000;26:81\u20134.","journal-title":"Nat Genet"},{"key":"1987_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/humu.22904","volume":"36","author":"RD Machado","year":"2015","unstructured":"Machado RD, Southgate L, Eichstaedt CA, Aldred MA, Austin ED, Best DH, Chung WK, Benjamin N, Elliott CG, Eyries M, et al. Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects. Hum Mutat. 2015;36:1113\u201327.","journal-title":"Hum Mutat"},{"key":"1987_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1465-9921-12-99","volume":"12","author":"N Pfarr","year":"2011","unstructured":"Pfarr N, Szamalek-Hoegel J, Fischer C, Hinderhofer K, Nagel C, Ehlken N, Tiede H, Olschewski H, Reichenberger F, Ghofrani AH, et al. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations. Respir Res. 2011;12:99.","journal-title":"Respir Res"},{"key":"1987_CR7","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41467-018-03672-4","volume":"9","author":"S Gr\u00e4f","year":"2018","unstructured":"Gr\u00e4f S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 2018;9:1416.","journal-title":"Nat Commun"},{"key":"1987_CR8","doi-asserted-by":"publisher","first-page":"1801899","DOI":"10.1183\/13993003.01899-2018","volume":"53","author":"NW Morrell","year":"2019","unstructured":"Morrell NW, Aldred MA, Chung WK, Elliott CG, Nichols WC, Soubrier F, Trembath RC, Loyd JE. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 2019;53:1801899.","journal-title":"Eur Respir J"},{"key":"1987_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1042\/CS20160930","volume":"131","author":"CA Eichstaedt","year":"2017","unstructured":"Eichstaedt CA, Song J, Rodr\u00edguez Viales R, Pan Z, Benjamin N, Fischer C, Hoeper M, Ulrich S, Hinderhofer K, Gr\u00fcnig E. First identification of Kr\u00fcppel-like factor 2 mutation in heritable pulmonary arterial hypertension. Clin Sci (Lond). 2017;131:689\u201398.","journal-title":"Clin Sci (Lond)"},{"key":"1987_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1056\/NEJM200108023450503","volume":"345","author":"RC Trembath","year":"2001","unstructured":"Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Gali\u00e8 N, Loyd JE, Humbert M, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001;345:325\u201334.","journal-title":"N Engl J Med"},{"key":"1987_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1161\/01.CIR.0000153798.78540.87","volume":"111","author":"RE Harrison","year":"2005","unstructured":"Harrison RE, Berger R, Haworth SG, Tulloh R, Mache CJ, Morrell NW, Aldred MA, Trembath RC. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. Circulation. 2005;111:435\u201341.","journal-title":"Circulation"},{"key":"1987_CR12","doi-asserted-by":"publisher","first-page":"e001887","DOI":"10.1161\/CIRCGEN.117.001887","volume":"11","author":"N Zhu","year":"2018","unstructured":"Zhu N, Gonzaga-Jauregui C, Welch CL, Ma L, Qi H, King AK, Krishnan U, Rosenzweig EB, Ivy DD, Austin ED, et al. Exome sequencing in children with pulmonary arterial hypertension demonstrates differences compared with adults. Circ Genom Precis Med. 2018;11:e001887.","journal-title":"Circ Genom Precis Med."},{"key":"1987_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13073-018-0566-x","volume":"10","author":"N Zhu","year":"2018","unstructured":"Zhu N, Welch CL, Wang J, Allen PM, Gonzaga-Jauregui C, Ma L, King AK, Krishnan U, Rosenzweig EB, Ivy DD, et al. Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease. Genome Med. 2018;10:56.","journal-title":"Genome Med"},{"key":"1987_CR14","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1042\/CS20160531","volume":"130","author":"J Song","year":"2016","unstructured":"Song J, Eichstaedt CA, Rodr\u00edguez Viales R, Benjamin N, Harutyunova S, Fischer C, Gr\u00fcnig E, Hinderhofer K. Identification of genetic defects in pulmonary arterial hypertension by a new gene panel diagnostic tool. Clin Sci (Lond). 2016;130:2043\u201352.","journal-title":"Clin Sci (Lond)"},{"key":"1987_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1987_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2008","unstructured":"Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FB, Hoogerbrugge N, Spurdle AB, Tavtigian SV. Group IUGVW: sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008;29:1282\u201391.","journal-title":"Hum Mutat"},{"key":"1987_CR17","doi-asserted-by":"publisher","first-page":"204589401987219","DOI":"10.1177\/2045894019872192","volume":"9","author":"M Lerche","year":"2019","unstructured":"Lerche M, Eichstaedt CA, Hinderhofer K, Gr\u00fcnig E, Tausche K, Ziemssen T, Halank M, Wirtz H, Seyfarth HJ. Mutually reinforcing effects of genetic variants and interferon-beta 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients. Pulm Circ. 2019;9:2045894019872192.","journal-title":"Pulm Circ"},{"key":"1987_CR18","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1042\/BCJ20160002","volume":"473","author":"AM Evans","year":"2016","unstructured":"Evans AM, Mahmoud AD, Moral-Sanz J, Hartmann S. The emerging role of AMPK in the regulation of breathing and oxygen supply. Biochem J. 2016;473:2561\u201372.","journal-title":"Biochem J"},{"key":"1987_CR19","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.108.800938","volume":"119","author":"E Gr\u00fcnig","year":"2009","unstructured":"Gr\u00fcnig E, Weissmann S, Ehlken N, Fijalkowska A, Fischer C, Fourme T, Galie N, Ghofrani A, Harrison RE, Huez S, et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation. 2009;119:1747\u201357.","journal-title":"Circulation"},{"key":"1987_CR20","doi-asserted-by":"publisher","first-page":"2004229","DOI":"10.1183\/13993003.04229-2020","volume":"58","author":"D Montani","year":"2021","unstructured":"Montani D, Girerd B, Jais X, Laveneziana P, Lau EMT, Bouchachi A, Hascoet S, Gunther S, Godinas L, Parent F, et al. Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation. Eur Respir J. 2021;58:2004229.","journal-title":"Eur Respir J"},{"issue":"3","key":"1987_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1536\/ihj.20-711","volume":"62","author":"TM Wang","year":"2021","unstructured":"Wang TM, Wang SS, Xu YJ, Zhao CM, Qiao XH, Yang CX, Liu XY, Yang YQ. sox17 loss-of-function mutation underlying familial pulmonary arterial hypertension. Int Heart J. 2021;62(3):566\u201374.","journal-title":"Int Heart J"},{"key":"1987_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13073-019-0685-z","volume":"11","author":"N Zhu","year":"2019","unstructured":"Zhu N, Pauciulo MW, Welch CL, Lutz KA, Coleman AW, Gonzaga-Jauregui C, Wang J, Grimes JM, Martin LJ, He H, et al. Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension. Genome Med. 2019;11:69.","journal-title":"Genome Med"},{"key":"1987_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/cge.12869","volume":"91","author":"P Navas Tejedor","year":"2017","unstructured":"Navas Tejedor P, Tenorio Castano J, Palomino Doza J, Arias P, Gordo G, Lopez Meseguer M, Roman Broto A, Lapunzina P, Escribano Subias P. An homozygous mutation in KCNK3 is associated with an aggressive form of hereditary pulmonary arterial hypertension. Clin Genet. 2017;91:453\u20137.","journal-title":"Clin Genet"},{"key":"1987_CR24","doi-asserted-by":"publisher","first-page":"a022871","DOI":"10.1101\/cshperspect.a022871","volume":"6","author":"R K\u00f6hling","year":"2016","unstructured":"K\u00f6hling R, Wolfart J. Potassium channels in epilepsy. Cold Spring Harb Perspect Med. 2016;6:a022871.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1987_CR25","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1183\/13993003.00026-2016","volume":"47","author":"D Montani","year":"2016","unstructured":"Montani D, Lau EM, Dorfm\u00fcller P, Girerd B, Jais X, Savale L, Perros F, Nossent E, Garcia G, Parent F, et al. Pulmonary veno-occlusive disease. Eur Respir J. 2016;47:1518\u201334.","journal-title":"Eur Respir J"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-01987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-01987-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-01987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T08:12:38Z","timestamp":1648455158000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-01987-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,27]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1987"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-01987-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,27]]},"assertion":[{"value":"23 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients included in this study underwent genetic counselling and signed written informed consent for their data and samples to be used for research purposes. The Ethics Committee at Heidelberg University had no objections against this study (project identification codes 065\/2001 and S-426\/2017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"E.G., C.A.E. and K.H. report an issued patent \u201cGene panel specific for pulmonary hypertension and its uses\u201d European Patent ID: EP3507380. Z.S., M.S., D.C., M.Le. and J.K. declare that they have no competing interests related to this study. P.X. has received personal fees from MSD and OMT outside the submitted work. N.B. received speaker fees from Actelion pharmaceuticals \/ Janssen Medical, Bayer HealthCare and MSD, outside the submitted work. BE received travel fees, con-sulting fees, speaking fees, and\/or honoraria from Actelion, MSD, Bayer and OMT, outside the submitted work. H.A.G. received consulting fees and or payment or honoraria for lectures from Actelion, Janssen, Bayer, MSD, Acceleron, Gossamer Bio, Novartis, Pfizer outside the submitted work. H.K. reports grants from GSK and Actelion and personal fees from Pfizer, GSK, Bayer, United Therapeutics, Actelion and Jansen outside the submitted work. H.G. reports personal fees from Actelion, AstraZeneca, Bayer, BMS, GSK, Janssen-Cilag, Lilly, MSD, Novartis, OMT, Pfizer, and United Therapeutics outside the submitted work. H.J.S. reports consulting fees from Actelion\/Janssen and speaker fees for Actelion, Bayer, GSK, Janssen and MSD outside the submitted work. K.M. reports personal speaker honoraria from Janssen, MSD, GSK outside the submitted work. K.M.O. received fees for lectures and\/or consultations from Acceleron, Actelion, Bayer, GSK, Janssen, MSD, Pfizer and United Therapeutics outside the submitted work. M.La. received con-sultancy or lecture honoraria from Actelion, Bayer, BRAHMS \u2013 Thermo Fisher Scientific, Daiichi-Sankyo, MSD and Bristol-Myers Squibb-Pfizer outside the submitted work. M.H. has re-ceived personal fees for consultations and lectures from Acceleron, Actelion, AstraZeneca, Bayer, BerlinChemie, GSK, Janssen-Cilag, MSD, and Novartis, outside the publication. M.M.H. has re-ceived fees for consultations and\/or lecturers from Acceleron, Actelion, Bayer, GSK, Janssen, MSD and Pfizer, all outside the submitted work. N.S. received honoraria for presentations from Actelion outside the submitted work. R.E. received honoraria for lectures from GSK, United Therapeutics, OMT, Janssen, outside the submitted work. S.H. received honoraria for lectures, consultancy, or both from Actelion, AOP, Bayer\/MSD, GSK, Novartis, OMT, Pfizer, and United Therapeutics out-side the submitted work. S.R. has received honoraria for lectures, consultancy, or both from Ac-tavis, Actelion, Bayer, GSK, Lilly, Novartis, Pfizer, and United Therapeutics outside the submitted work. T.L. received consulting fees from Acceleron Pharma, Actelion\/Janssen-Cilag, Bayer, GSK, MSD and personal honoraria for lectures from Actelion\/Janssen-Cilag, BMS, MSD, Pfizer outside the submitted work. EG has received grants and personal fees from Actelion, Bayer AG, and MSD; grants from GSK, Novartis, and United Therapeutics and personal fees from SCOPE, OrPha Swiss GmbH, and Zurich Heart House, outside the submitted work. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}